Emerson to Present at J.P. Morgan's 2024 Industrials Conference
Emerson to Present at J.P. Morgan's 2024 Industrials Conference
PR Newswire
ST. LOUIS, March 6, 2024
ST. LOUIS, March 6, 2024 /PRNewswire/ -- Emerson (NYSE: EMR) today announced Chief Operating Officer, Ram Krishnan, and Chief Financial Officer, Mike Baughman, will present at J.P. Morgan's 2024 Industrials Conference on Wednesday, March 13th in New York City, New York. The presentation will begin at 3:00 p.m. Eastern Time, 2:00 p.m. Central Time.
The audio will be webcast and archived on Emerson's website at www.Emerson.com/investors.
About Emerson
Emerson (NYSE: EMR) is a global technology and software company providing innovative solutions for the world's essential industries. Through its leading automation portfolio, including its majority stake in AspenTech, Emerson helps hybrid, process and discrete manufacturers optimize operations, protect personnel, reduce emissions and achieve their sustainability goals. For more information, visit Emerson.com.
Emerson uses our Investor Relations website, www.Emerson.com/investors, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.
Contacts
Investors
Colleen Mettler
(314) 553-2197
View original content to download multimedia:https://www.prnewswire.com/news-releases/emerson-to-present-at-jp-morgans-2024-industrials-conference-302080521.html
SOURCE Emerson
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise